Ophthalmology

The AJMC^® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Dry eye | Image credit: Kryuchka Yaroslav - stock.adobe.com

Reproxalap Receives Complete Response Letter From FDA for Use in Dry Eye Disease

By Julia Bonavitacola

April 3rd 2025

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish efficacy, according to the FDA.

Astigmatism | Image credit: Zarina Lukash - stock.adobe.com

Prevalence, Severity of Astigmatism Increased in Children After Pandemic

By Julia Bonavitacola

March 26th 2025

Dry eye | Image credit: lenblr - stock.adobe.com

Retraction: Water-Free Topical Cyclosporine Improved Dryness Score in Dry Eye

By Julia Bonavitacola

March 17th 2025

Dry eye | Image credit: lenblr - stock.adobe.com

Water-Free Topical Cyclosporine Improved Dryness Score in Dry Eye

By Julia Bonavitacola

March 12th 2025

Vision test | Image credit: Miroslav110 - stock.adobe.com

Racial, Ethnic Minorities Underrepresented in Clinical Trials in Macular Edema

By Julia Bonavitacola

March 5th 2025

Continuing Medical Education

April 3rd 2025

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

2.0 Credits / Ophthalmology/Optometry

April 3rd 2025

Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies

1.5 Credits / Ophthalmology, Optometry

April 3rd 2025

Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes

1.5 Credits / Ophthalmology/Optometry

April 3rd 2025

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology

April 3rd 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

More News

Expert on glaucoma

March 14th 2022

Novel Therapy in Glaucoma: Sustained Delivery Implants

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.

technology

March 9th 2022

Teleretinal Screening Appears Effective at Diagnosing Diabetic Retinopathy

Jared Kaltwasser

The meta-analysis found insufficient evidence to assess the validity of the screening in diagnosing age-related macular degeneration.

Robert Fante, MD

March 7th 2022

Dr Robert Fante: More Data Will Provide More Insight Into Use of Teprotumumab for TED

As more data are gathered on teprotumumab for use in thyroid eye disease (TED), we’ll have a better understanding of which subgroups respond better or worse to the treatment, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.

Steven Yeh, MD

March 7th 2022

Dr Steven Yeh Discusses Xipere Delivery Mechanism and Benefits

Hayden E. Klein

Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, explains the delivery mechanism and benefits of Xipere for macular edema.

Experts on glaucoma

March 7th 2022

Use of Rho Kinase Inhibitors in Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Panelists discuss the role of rho kinase inhibitors in glaucoma management respective to cost, efficacy, and ease of use.

Expert on glaucoma

March 7th 2022

Addressing Patient Adherence in Glaucoma Management

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.

March 5th 2022

Early Retinal Vascular Density Deficiency May Indicate Risk of Visual Field Loss in Glaucoma

A small study found that decreased retinal vascular density identified by optical coherence tomography angiography may be linked to faster visual field loss at extended follow-up.

Judith Lavrich, MD, and Jordan Hamburger

February 28th 2022

Researchers: Future Investigations on Screen Time, Eye Health Are Warranted

Judith Lavrich, MD, and Jordan Hamburger discuss the need for more research on the impact of screen time on eye health following their study on virtual school and children's eyesight.

Expert on glaucoma

February 28th 2022

Factors Guiding Selection of Therapy for Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.

Expert on glaucoma

February 28th 2022

Considering Generic Vs Branded Therapy for Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.

Image of swollen eyelid

February 25th 2022

Case-Control Study Identifies Potential Link Between COVID-19, Chronic Dacryoadenitis

SARS-CoV-2 might target lacrimal glands, causing eyelid swelling due to chronic dacryoadenitis after COVID-19 infection.

David Ramsey MD, PhD, MPH

February 22nd 2022

Dr David Ramsey Explains the Importance of Eye Examinations in Patients With Diabetes

David Ramsey, MD, PhD, MPH, outlines why patients with diabetes should undergo regular eye examinations.

Expert on glaucoma

February 21st 2022

An Overview of Treatment Options for Glaucoma

Neil Minkoff, MD Nathan Radcliffe, MD Terri-Diann Pickering, MD Maria Lopes, MD, MS Kevin U. Stephens, Sr, JD, MD

A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.

Experts on glaucoma

February 21st 2022

Glaucoma: Utilization Management and Patient Access to Therapy

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.

James Auran, MD

February 18th 2022

Dr James Auran Outlines How to Address Shortages of Ophthalmic Trauma Care Providers

James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.

eye scan

February 16th 2022

Xipere for Macular Edema Associated With Uveitis Launches in United States

Laura Joszt, MA

The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.

Expert on Glaucoma

February 14th 2022

Goals of Therapy When Treating Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

Experts highlight early detection and the goals of therapy when managing patients with glaucoma.

Expert on glaucoma

February 14th 2022

The Importance of Vision Preservation in Patients With Glaucoma

Neil Minkoff, MD Terri-Diann Pickering, MD Kevin U. Stephens, Sr, JD, MD Maria Lopes, MD, MS Nathan Radcliffe, MD

A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.

Image of an eye

February 11th 2022

Plasma THC Levels Associated With Reduced Intraocular Pressure in Healthy Adults

A recent analysis found a strong negative correlation between plasma THC levels and intraocular pressure in healthy adults after smoking cannabis.

Anne Barmettler, MD

February 7th 2022

Dr Anne Barmettler Discusses Potential Adverse Events Associated With Teprotumumab

Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.

Leon Herndon Jr, MD

February 3rd 2022

Dr Leon Herndon on Tailoring Glaucoma Care for Older Patients

Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.

closed eye

January 31st 2022

FDA Approves Faricimab to Treat Wet AMD and DME

Laura Joszt, MA

This represents the approval of the first bispecific antibody to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME).

technology image

January 29th 2022

Could AI–Based Real-Time Surgical Guidance Reduce Complications During Cataract Surgery?

A recent study suggests a conceptual deep neural network–based surgical guidance platform is precise and has potential as a valuable tool during phacoemulsification procedures.

Aaron Lee, MD

January 25th 2022

Dr Aaron Lee: AI in Ophthalmology Comes With Important Caveats

Aaron Lee, MD, an associate professor of ophthalmology at the University of Washington, discusses some limitations of artificial intelligence (AI) in the ophthalmology field.

Graphical image of eye

January 23rd 2022

Study Finds Association Between COVID-19 and Dry Eye Symptoms

One of the long-term effects of COVID-19 may be small fiber neuropathy in the ocular surface causing similar symptoms to dry eye disease and diabetic neuropathy, a recent study found.

Victoria Ly, MD, MPH

January 18th 2022

Dr Victoria Ly Outlines Potential Future Research on Vision Screening Follow-up Disparities

Victoria Ly, MD, MPH, explains potential next steps for her research on vision screening follow-up rate disparities among children in Arkansas.

AI-Based Anomaly Detection Holds Promise in Screening for Retinal Diseases, Study Says

January 17th 2022

AI-Based Anomaly Detection Holds Promise in Screening for Retinal Diseases, Study Says

Recent findings suggest that with more research, anomaly detection may be an option for general retinal disease screening and identification of novel presentations of common retinal diseases.

Judith Lavrich, MD, and Jordan Hamburger

January 12th 2022

Researchers Explain Next Steps for Studying the Ocular Effects of Virtual Learning

Judith Lavrich, MD, and Jordan Hamburger outline next steps for their research on virtual learning and pediatric eye health.

Futuristic eye image

January 9th 2022

Possible Correlations Found Between Aging, Visual Field Reliability Indices

A large real-world analysis assessed age-related changes in commonly used visual field reliability indices and the potential mechanisms behind the trends.

Close up of an eye

January 7th 2022

Retrospective Study Finds Neovascular Glaucoma Etiology May Affect Surgical Outcomes

One-year outcomes varied among patients with differing neovascular glaucoma etiologies, but many achieved meaningful vision after surgical treatment that included glaucoma drainage devices.

...

5 6 7 8 9 10 11 12 13

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions